Lung Cancer
News
Afatinib approved for non-small cell lung tumors with growth factor mutations
News
Nintedanib and docetaxel provide small PFS advantage in NSCLC
Major finding: Median progression-free survival was 3.4 months for patients randomized to nintedanib and docetaxel, compared with 2.7 months for...
News
START trial keeps L-BLP25 immunotherapy alive in stage III NSCLC
Major finding: Median survival in patients who received initial concurrent chemoradiotherapy was 30.8 months with maintenance L-BLP25 vs.
News
Wedge resection in NSCLC: Is 15 mm the magic margin?
Major finding: Compared with a margin length of 5 mm, the adjusted risk of local recurrence was estimated to be 45% lower with a margin length of...
Conference Coverage
VeriStrat predicts second-line treatment response in advanced lung cancer
Major finding: VeriStrat ‘poor’ patients derived a significant survival benefit from chemotherapy, with a median survival of 6.38 months, vs.
News
Ganetespib trial hints at survival benefit in lung adenocarcinoma
Major finding: The ganetespib and docetaxel combination was superior to docetaxel and placebo, with median overall survival of 10.7 vs. 6.4 months...
News
Treating refractory and metastatic lung cancer
News
Survival equivalent with sublobar, lobar resection of stage Ia NSCLC
Major finding: Lung cancer–specific mortality was 7% with sublobar resection and 10% with lobar resection.Data source: Retrospective analysis of...
News
CDC urges doctors to help patients quit smoking
News
Real-world NLST results show CT scans find more early-stage lung cancers
Major Finding: The sensitivity and specificity of CT for lung cancer detection were 93.8% and 73.4%, respectively; for radiography, sensitivity...
News
Ultralow-dose CT bests X-Ray for lung cancer follow-up, but is it enough?
Major finding: Minimal-dose CT detected 94.2% of new or recurrent lung cancer, compared with 21.1% for chest x-ray.Data source: Prospective study...